Clinical Trials Sponsored by Spectranetics Corporation

Total 6440 results

Spectranetics Corporation

Recruiting

Tack Optimized Balloon Angioplasty Post-Market Study (TOBA PMS)

Peripheral Arterial Disease | Peripheral Vascular Diseases | PAD | PAD - Peripheral Arterial Disease | Dissection | Arterial Dissection

United States
Spectranetics Corporation

Completed

STELLAREX: ILLUMENATE Global and In-Stent Restenosis (ISR) (ILLUMENATE)

Peripheral Arterial Disease

Belgium, Germany, New Zealand, France, United Kingdom, Australia, Poland, Austria, Italy, Spain
Spectranetics Corporation

Completed

ILLUMENATE EU Randomized Clinical Trial (EU RCT)

Peripheral Arterial Disease | Claudication

Germany
Spectranetics Corporation

Completed

Valvuloplasty Scoring Balloon Catheter First-in-Man Study

Aortic Valve Stenosis

Canada
Spectranetics Corporation

Completed

CVI Drug Coated Balloon First In Human Trial

Peripheral Arterial Disease

Germany
Spectranetics Corporation

Completed

CELLO - CLiRpath® Excimer Laser System to Enlarge Lumen Openings (CELLO)

Peripheral Artery Disease
Spectranetics Corporation

Completed

Atherectomy By Laser Ablation With Turbo-Elite (ABLATE)

Peripheral Arterial Disease | Peripheral Vascular Disease
Spectranetics Corporation

Completed

An Evaluation of a Clinical Algorithm With Turbo-Power Following Treatment of Specific Morphologies (REX)

Peripheral Arterial Disease

United States
Spectranetics Corporation

Completed

ModificatiOn and Treatment of stenoseD Calcified inFrainguinal Lesions With Laser atherectomY in a Pilot Study (MODIFY)

Peripheral Arterial Disease

Belgium
Spectranetics Corporation

Completed

TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions

Peripheral Arterial Disease

United States
Spectranetics Corporation

Completed

Pharmacokinetic Study of Drug-coated Angioplasty Balloons in the Superficial Femoral or Popliteal Arteries: (PK)

Peripheral Artery Disease

New Zealand
Spectranetics Corporation

Completed

ILLUMENATE Pivotal Post-Approval Study (PAS)

Peripheral Artery Disease

United States, Austria
Spectranetics Corporation

Completed

ILLUMENATE Below-The-Knee (BTK) Arteries: a Post Market Clinical Study (BTK PMS)

Peripheral Arterial Disease

Netherlands, Germany, United Kingdom
Spectranetics Corporation

Completed

Stellarex Vascular E-Registry (SAVER)

Peripheral Arterial Disease

Belgium, Germany, France, United Kingdom, Austria, Italy
Spectranetics Corporation

Completed

Pivotal Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon (ILLUMENATE)

Peripheral Arterial Disease

United States, Austria
Spectranetics Corporation

Completed

Randomized Study of Laser and Balloon Angioplasty Versus Balloon Angioplasty to Treat Peripheral In-stent Restenosis (EXCITE ISR)

Peripheral Arterial Disease

United States, Puerto Rico
KCRI
Spectranetics Corporation

Terminated

ThromboAblation in Acute Myocardial Infarction (TAAMI)

ST Elevation Acute Myocardial Infarction

Poland
Spectranetics Corporation
Philips Healthcare

Suspended

Stellarex DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries (ILLUMENATE-BTK)

Critical Limb Ischemia

United States, Belgium, Australia, Germany, Austria
Spectranetics Corporation
Yale University

Withdrawn

First in Human Study of Winsor Laser Catheter: A Prospective Registry to Evaluate The Safety and Performance of the Winsor Laser Catheter in the Treatment of In-Stent Restenosis

Femoropopliteal In-Stent Restenosis

Colombia
Yale University
Spectranetics Corporation

Completed

Bridge Occlusion Balloon in Lead Extraction Procedure

C.Surgical Procedure; Cardiac | Cardiac Dysrhythmia | Disorder of Pacing Function

United States
University of Florida
Spectranetics Corporation

Withdrawn

Endo-biliary Laser Excision of Biliary Stenoses

Bile Duct Obstruction | Biliary Tract Disease
VIVA Physicians
W.L.Gore & Associates; Spectranetics Corporation

Terminated

Study to Evaluate the Safety and Performance of Spectranetics Laser w/Adjunct PTA and Gore Viabahn Endoprosthesis for Treatment of SFA Instent Restenosis (SALVAGE)

Restenosis

United States
Flanders Medical Research Program
Spectranetics Corporation

Terminated

EXCimEr Laser for Long lENgTh Lesions in Below-The-Knee Arteries Study (EXCELLENT-BTK)

Peripheral Arterial Occlusive Disease

Belgium
Midwest Cardiovascular Research Foundation
Spectranetics Corporation

Unknown

Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention (PacTAP)

Peripheral Arterial Disease | Restenosis

United States
Spectranetics Corporation
CBCC-VIBGYOR Research Pvt. Ltd.

Completed

Multicenter Study to Evaluate the Procedural Safety and Efficacy of ELCA in CAD (ELCA-CAD)

Coronary Artery Disease

India
Englewood Hospital and Medical Center
Spectranetics Corporation

Terminated

Paclitaxel for the Treatment of Upper-Extremity Arteriovenous Access Fistula Stenosis (PaciFIST-1)

Fistula Stenosis

United States
GenMont Biotech Incorporation
Biomedical Development Corporation

Completed

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis (PAR)

Probiotics | Perennial Allergic Rhinitis | Lactobacillus Paracasei GMNL-32 (eN-Lac®)

Taiwan
Boston Scientific Corporation
Guidant Corporation

Completed

Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead

Ventricular Fibrillation | Ventricular Tachycardia

France
Boston Scientific Corporation
Guidant Corporation

Completed

Shockless Implant Evaluation (SIMPLE)

Ventricular Fibrillation | Ventricular Tachycardia

Germany, Spain, Canada, Israel, Netherlands, France, Finland, United Kingdom, Austria, Malaysia, Thailand, Hong Kong, Sweden, Hungary, Australia, Czechia, Norway, Poland
Boston Scientific Corporation
Guidant Corporation

Completed

Feature Assessment Study for Indications Based Programming (FASt-IBP)

Heart Failure | Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Flutter

Germany, Spain, Switzerland, China, Austria, Belgium, France, Greece, Latvia, Netherlands, Slovakia
Boston Scientific Corporation
Guidant Corporation

Completed

Japanese Assessment of Indication Based Programming (JASMINE)

Heart Failure | Arrhythmias, Cardiac

Japan
Boston Scientific Corporation
Guidant Corporation

Completed

Quick ICD Study: Is Extensive Electrophysiological Testing Before, During and After ICD-Implantation Still Necessary ? (Quick ICD)

Cardiac Arrest

Germany
Rgene Corporation
American BriVision Corporation

Not yet recruiting

Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy

Nonsquamous Nonsmall Cell Neoplasm of Lung

Taiwan
Rgene Corporation
American BriVision Corporation

Not yet recruiting

A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer

Pancreatic Cancer
Boston Scientific Corporation
Guidant Corporation

Terminated

MODULA Modul 7 VRR

Atrial Fibrillation

Germany
Boston Scientific Corporation
EKOS Corporation

Completed

ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism (ULTIMA)

Submassive Pulmonary Embolism

Germany, Switzerland
Boston Scientific Corporation
EKOS Corporation

Completed

Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism (OPTALYSE PE)

Pulmonary Embolism and Thrombosis

United States, United Kingdom
Boston Scientific Corporation
EKOS Corporation

Completed

Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy (SEATTLE II)

Pulmonary Embolism | Acute Pulmonary Embolism | Pulmonary Thromboembolism | Massive Pulmonary Embolism | Sub-massive Pulmonary Embolism

United States
Boston Scientific Corporation
Guidant Corporation

Completed

MODULA Modul 5 BEAT-HF

Heart Failure

Germany
Boston Scientific Corporation
Guidant Corporation

Terminated

MODULA-Study: Modul 10: Benefit of CRT-Therapy in CRT-Patients With QRS-Complex of 120 - 150 Ms

Heart Failure

Germany
Guidant Corporation
Boston Scientific Corporation

Completed

Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following (Cogent-4)

Heart Failure | Ventricular Tachycardia, Ventricular Fibrillation

Israel, Denmark
Boston Scientific Corporation
EKOS Corporation

Withdrawn

Registry Study to Evaluate the Performance and Safety of Roxwood Medical Catheters in Arteries of Participants With a Stenotic Lesion or Chronic Total Occlusion (CTO)

Coronary Artery Disease | Atherosclerosis | Peripheral Artery Disease | Chronic Total Occlusion

United States
Boston Scientific Corporation
EKOS Corporation

Completed

Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System (ACCESS PTS)

Deep Vein Thrombosis | Post-thrombotic Syndrome

United States
Guidant Corporation
Boston Scientific Corporation

Completed

Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device (SEPTAL-CRT)

Ventricular Fibrillation | Ventricular Tachycardia | Systolic Heart Failure

France, Spain
Shanghai Antengene Corporation Limited

Terminated

A Study to Evaluating the Pharmacokinetics, Safety, and Efficacy of ATG 016 Monotherapy in IPSS-R Intermediate Risk and Above Myelodysplastic Syndrome (MDS) (HATCH)

Myelodysplastic Syndrome

China
Shanghai Antengene Corporation Limited

Terminated

A Study of Evaluating the Safety and Efficacy of ATG-008 for Advanced Solid Tumors (BUNCH)

Advanced Solid Tumors

China
Shanghai Antengene Corporation Limited

Terminated

A Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of ATG 016 Monotherapy in Patients With Advanced Solid Tumors (REACH)

Advanced Solid Tumors

China
Mitsubishi Tanabe Pharma Corporation
Kureha Corporation

Completed

A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)

Chronic Kidney Disease

United States, France, Italy, Ukraine, Argentina, Mexico, Poland, Canada, Brazil, Russian Federation, Czechia, Puerto Rico
Mitsubishi Tanabe Pharma Corporation
Kureha Corporation

Completed

A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)

Chronic Kidney Disease

United States, Poland, Ukraine, Spain, Argentina, Mexico, Canada, Brazil, Russian Federation, Puerto Rico, Germany, Czechia
Pulmonx Corporation

Recruiting

Zephyr Valve Japan Post-Marketing Surveillance

Emphysema | COPD | Severe Emphysema

Japan

Clinical Trials Sponsored by Spectranetics Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations